A government official said the addressable market would now be in booster shots, since most of the people eligible for Covid-19 vaccines have already received both the doses. "Both Gennova Biopharmaceuticals and Bharat Biotech have also conducted the trials of their new vaccines as boosters. It's better to position any new vaccine now as a precaution dose," one of the persons cited earlier told ET. "Most people have already taken their primary doses."
